Celebrating its 10th successful year, SCOPE Summit 2019 takes place February 18-21 in Orlando, FL. Over the course of four stimulating days of in-depth discussions in 19 different conferences, 3 plenary keynote sessions, and the ever-popular interactive breakout discussions, the programming focuses on advances and innovative solutions in all aspects of clinical trial planning, management and operations, including: Site Selection and Management, Patient Engagement, Recruitment and Retention, Protocol Optimization, Feasibility, Data Strategy & Analytics, Artificial Intelligence (AI), Sensors and Wearables, Project Management, Outsourcing, Forecasting, Budgeting and Contracting, Quality (QbD) in Trial Conduct, Risk-Based Monitoring, Post-Marketing Studies, Observational Research, Clinical Biomarker Strategy, Clinical Supply Chain, Precision Medicine, and Biospecimens and Central Lab Solutions.Find out more »
Exclusively focusing on empowering translational neurodegenerative research, the 7th Annual World CNS Summit is the only industry-specific conference to help bridge the gap for translational development.
Bringing together over 100 senior scientists and executives from across biopharma and academia, join us to challenge traditional thinking in the development of efficacious treatments against neurodegeneration.
This is a unique opportunity to engage with the leading minds in the neurodegenerative space from academia, pharma, biotech and leading consortia to advance the successful development of the next generation of therapies.Find out more »
AD/PD 2019, the 14th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders
AD/PD 2019, the 14th International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders, will build on the well-earned reputation of previous AD/PD Conferences for unraveling the mechanisms and improving the treatment of Alzheimer’s, Parkinson’s and other related neurodegenerative diseases.
Renowned for its broad, multidisciplinary approach, it uniquely brings together Alzheimer’s Conferences and Parkinson’s Conferences, through exploring overlaps and congruent results, to provide attendees unparalleled and powerful insights into all the latest research and developments, clinical trials, and treatments.
AD/PD is the conference for all those engaged in the neurodegeneration field, from basic scientists to clinical investigators, and from established leaders to young upcoming talents. AD/PD is your opportunity to present your findings at the international level.Find out more »